The role of IL-15 signaling in the induction of innate antiviral responses

Current Signal Transduction Therapy

Volumn 2, Issue 3, 2007, Pages 180-185

  Gill, Navkiran ^a   Lauzon, Nicole M ^a   Ashkar, Ali A ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

IFNs; IL 15; Innate immunity; NK NKT cells; Viral infection

Indexed keywords

BETA INTERFERON; CYTOKINE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 2 RECEPTOR BETA;

ANTIGEN PRESENTING CELL; ANTIVIRAL ACTIVITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME ACTIVATION; ENZYME RELEASE; HUMAN; INFECTION CONTROL; INNATE IMMUNITY; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN STRUCTURE; RECEPTOR BINDING; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRUS INFECTION;

EID: 34848870852     PISSN: 15743624     EISSN: None     Source Type: Journal    
DOI: 10.2174/157436207781745355     Document Type: Review

References (99)

1. Fawaz LM, Sharif-Askari E, Menezes J. Up-regulation of NK cytotoxic activity via IL-15 induction by different viruses: a comparative study. J Imunol 1999; 163: 4473-4480.
2. Flamand L, Stefanescu I, Menezes J. Human herpesvirus-6 enhances natural killer cell cytotoxicity via IL-15. J Clin Invest 1996; 97: 1373-1381.
3. Ahmad A, Sharif-Askari E, Fawaz L, Menezes J. Innate immune response of the human host to exposure with herpes simplex virus type 1: in vitro control of the virus infection by enhanced natural killer activity via interleukin-15 induction. J Virol 2000; 74: 7196-7203.
4. Gosselin J, Tomolu A, Gallo RC, Flamand L. Interleukin-15 as an activator of natural killer cell-mediated antiviral response. Blood 1999; 94: 4210-4219.
5. Tran P, Ahmad R, Xu J, Ahmad A, Menezes J. Host's innate immune response to fungal and bacterial agents in vitro: up-regulation of interleukin-15 gene expression resulting in enhanced natural killer cell activity. Immunology 2003; 109: 263-270.
6. Ing R, Gros P, Stevenson MM. Interleukin-15 enhances innate and adaptive immune responses to blood-stage malaria infection in mice. Infect Immun 2005; 73: 3172-3177.
7. Umemura M, Nishimura H, Hirose K, Matsuguchi T, Yoshikai Y. Overexpression of IL-15 in vivo enhances protection against Mycobacterium bovis bacillus Calmette-Guerin infection via augmentation of NK and T cytotoxic 1 responses. J Immunol 2001; 167: 946-956.
8. Umemura M, Hirose K, Wajjwalku W, et al. Impaired IL-15 production associated with susceptibility of murine AIDS to mycobacterial infection. J Leukoc Biol 2001; 69: 138-148.
9. Umemura M, Nishimura H, Saito K, et al. Interleukin-15 as an immune adjuvant to increase the efficacy of Mycobacterium bovis bacillus calmette-guerin vaccination. Infect Immun 2003; 71: 6045-6048.
10. Fehniger TA, Caligiuri MA. Interleukin 15: biology and relevance to human disease. Blood 2001; 97: 14-32.
11. Yamaji K, Nabeshima S, Murata M, et al. Interferon-alpha/beta upregulate IL-15 expression in vitro and in vivo: analysis in human hepatocellular carcinoma cell lines and in chronic hepatitis C patients during interferon-alpha/beta treatment. Cancer Immunol Immunother 2005; 1-10.
12. Waldmann TA, Tagaya Y. The multifaceted regulation of interleukin-15 expression and the role of this cytokine in NK cell differentiation and host response to intracellular pathogens. Annu Rev Immunol 1999; 17: 19-49.
13. Ohteki T. Critical role for IL-15 in innate immunity. Curr Mol Med 2002; 2: 371-380.
14. Giri JG, Kumaki S, Abdieh M, et al. Identification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptor. EMBO J 1995; 14: 3654-3663.
15. Barlic J, McDermott DH, Merrell MN, Gonzales J, Via LE, Murphy PM. Interleukin (IL)-15 and IL-2 reciprocally regulate expression of the chemokine receptor CX3CR1 through selective NFAT1- and NFAT2-depeodent mechanisms. J Biol Chem 2004; 279: 48520-48534.
16. Lodolce JP, Burkett PR, Koka RM, Boone DL, Ma A. Regulation of lymphoia homeostasis by interleukin-15. Cytokine Growth Factor Rev 2002; 13: 429-439.
17. Waldmann TA, Dubois S, Tagaya Y. Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. Immunity 2001; 14: 105-110.
18. Kennedy MK, Glaccum M, Brown SN, et al. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J Exp Med 2000, 191: 771-780.
19. Fehniger TA, Suzuki K, VanDeusen JB, Cooper MA, Freud AG, Caligiuri MA. fatal leukemia in interleukin-15 transgenic mice. Blood Cells Mol Dis 2001; 27: 223-230.
20. Anderson DM, Kumaki S, Ahdieh M, et al. Functional characterization of the human interleukin-15 receptor alpha chain and close linkage of IL15RA and IL2RA genes. J Biol Chem 1993; 270: 29862-29869.
21. Giri JG, Anderson DM, Kumaki S, Park LS, Grabstein KH, Cosman D. IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. J Leukoc Biol 1995; 57: 763-766.
22. Schluns KS, Stoklasek T, Lefrancois L. The roles of interleukin-15 receptor alpha: trans-presentation, receptor component, or both? Int J Biochem Cell Biol 2005; 37: 1567-1571.
23. Dubois S, Mariner J, Waldmann TA, Tagaya Y. IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells. Immunity 2002; 17: 537-547.
24. Musso T, Calosso L, Zucca M, et al. Human monocytes constitutively express membrane-bound, biologically active, and interferon-gamma-upregulated interleukin-15. Blood 1999; 93: 3531-3539.
25. Budagian V, Bulanova E, Orinska Z, et al. Reverse signaling through membrane-bound interleukin-15. J Biol Chem 2004; 279: 42192-42201.
26. Kobayashi H, Dubois S, Sato N, et al. Role of trans-cellular IL-15 prsentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance. Blood 2005; 105: 721-727.
27. Neely GG, Epelman S, Ma LL, et al. Monocyte surface-bound IL-15 can function as an activating receptor and participate in reverse signaling. J Immunol 2004; 172: 4225-4234.
28. Sandau MM, Schluns KS, Lefrancois L, Jameson SC. Cutting edge: transpresentation of IL-15 by bone marrow-derived cells necessitates expression of IL-15 and IL-15R alpha by the same cells. J Immunol 2004; 173: 6537-6541.
29. Budagian V, Bulanova E, Orinska Z, et al. Natural soluble interleukin-15Ralpha is generated by cleavage that involves the tumor necrosis factor-alpha-converting enzyme (TACE/ADAM17). J Biol Chem 2004; 279: 40368-40375.
30. Mortier E, Bernard J, Plet A, Jacques Y. Natural, proteolytic release of a soluble form of human IL-15 receptor alpha-chain that behaves as a specific, high affinity IL-15 antagonist. J Immunol 2004; 173: 1681-1688.
31. Waldmann T, Tagaya Y, Bamford R. Interleukin-2, interleukin-15, and their receptors. Int Rev Immunol 1998; 16: 205-226.
32. Demoulin JB, Renauld JC. Signalling by cytokines interacting with the interleukin-2 receptor gamma chain. Cytokines Cell Mol Ther 1998; 4: 243-256.
33. Kovanen PE, Leonard WJ. Cytokines and immunodeficiency diseases: critical roles of the gamma(c)-dependent cytokines interleukins 2, 4, 7, 9, 15, and 21, and their signaling pathways. Immunol Rev 2004; 202: 67-83.
34. Johnston JA, Kawamura M, Kirken RA, et al. Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 1994; 370: 151-153.
35. Johnston JA, Bacon CM, Finbloom DS, et al. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc Natl Acad Sci USA 1995; 92: 8705-8709.
36. Lin JX, Migone TS, Tsang M, et al. The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 1995; 2: 331-339.
37. Ortmann RA, Cheng T, Visconti R, Frucht DM, O'Shea JJ. Janus kinases and signal transducers and activators of transcription: their roles in cytokine signaling, development and immunoregulation. Arthritis Res 2000; 2: 16-32.
38. Calo V, Migliavacca M, Bazan V, et al. STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol 2003; 197: 157-168.
39. Bulanova E, Budagian V, Orinska Z, Krause H, Paus R, Bulfone-Paus S. Mast cells express novel functional IL-15 receptor alpha isoforms. J Immunol 2003; 170: 5045-5055.
40. Koka R, Burkett P, Chien M, Chai S, Boone DL, Ma A. Cutting edge: murine dendritic cells require IL-15R alpha to prime NK cells. J Immunol 2004; 173: 3594-3598.
41. Fehniger TA, Carson WE, Caligiuri MA. Costimulation of human naturat killer cells is required for interferon gamma production. Transplant Proc 1999; 31: 1476-1478.
42. Ahmad A, Ahmad R, Toma E, Morisset R, Menezes J. Impaired induction of IL-15 in response to herpes simplex virus type 1 infection in peripheral blood mononuclear cells of HIV-infected patients. Aids 2000; 14: 744-746.
43. Atedzoe BN, Ahmad A, Menezes J. Enhancement of natural killer cell cytotoxicity by the human herpesvirus-7 via IL-15 induction. J Immunol 1997; 159: 4966-4972.
44. Loubeau M, Ahmad A, Toma E, Menezes, J. Enhancement of natural killer and antibody-dependent cytolytic activities of the peripheral blood mononuclear cells of HIV-infected patients by recombinant IL-15. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16: 137-145.
45. Carson WE, Caligiuri MA. Interleukin 15: a potential player during the innate immune response to infection. Exp Parasitol 1996; 84: 291-294.
46. Fehniger TA, Shah MH, Turner MJ, et al. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implication for the innate immune response. J Immunol 1999; 162: 4511-4520.
47. Ashkar AA, Rosenthal KL, Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. J Virol 2003; 77: 10168-10171.
48. Milligan GN, Bernstein DI. Interferon-gamma enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology 1997; 229: 259-268.
49. Baccala R, Witherden D, Gonzalez-Quintial R, et al. Gamma delta T cell homeostasis is controlled by IL-7 and IL-15 together with subset-specific factors. J Immunol 2005, 174: 4606-4612.
50. Nishimura H, Yujima T, Kagimoto Y, et al. Intraepithelial {gamma} {delta} t cells may bridge a gap between innate immunity and acquired immunity to herpes simplex virus type 2. J Virol 2004; 78: 4927-4930.
51. Doherty TM, Seder RA, Sher A. Induction and regulation of IL-15 expression in marine macrophages. J Immunol 1996; 156: 735-741.
52. Mattei F, Schivoni G, Belardelli F, Tough DF. IL-15 is expressed by dendritic cells in response to type 1 IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation. J Immunol 2001; 167:1179-1187.
53. Liu G, Zhai Q, Schaffner D, et al. IL-15 induces IFN-beta and iNOS gene expression, and antiviral activity of murine macrophage RAW 264.7 cells. Immunol Lett 2004; 91: 171-178.
54. Gill N, Rosenthal KL, Ashkar AA. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection. J Virol 2005; 79: 4470-4478.
55. Koka R, Burkett PR, Chien M, et al. Interleukin (IL)-15R[alpha]-deficient natural killer cells survive in normal but not IL-15R[alpha]-deficient mice. J Exp Med 2003; 197: 977-984.
56. Vosshenrich CA, Ranson T, Samson SI, et al. Roles for common cytokine receptor gamma-chain-depondent cytokines in the generation, differentiation, and maturation of NK cell precursors and peripheral NK cells in vivo. J Immunol 2005; 174: 1213-1221.
57. Nguyen KB, Salazar-Mather TP, Dalod MY, et al. Coordinated and distinct rules for IFN-alpha beta, IL-12, and IL-15 regulation of NK cell responses to viral infection. J Immunol 2002; 169: 4279-4287.
58. Colucci F, Caligiuri MA, Di Santo JP. What does it take to make a natural killer? Nat Rev Immunol 2003; 3: 413-425.
59. Fehniger TA, Cooper MA, Nuovo GJ, et al. CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood 2003; 101: 3052-3057.
60. Carson WE, Fehniger TA, Haldar S, et al. A potential role for interieukin-15 in the regulation of human natural killer cell survival. J Clin Invest 1997; 99: 937-943.
61. Mastroianni CM, d'Ettorre G, Forcina G, et al. Interleukin-15 enhances neutrophil functional activity in patients with human immunodeficiency virus infection. Blood 2000; 96: 1979-1984.
62. Marks-Konczalik J, Dubois S, Losi JM, et al. IL-2-induced activation-induced cell death is inhibited in IL- 15 transgenic mice. Proc Natl Acad Sci USA 2000; 97: 11445-11450.
63. Minagawa M, Watanabe H, Miyaji C, et al. Enforced expression of Bcl-2 restores the number of NK cells, but does not rescue the impaired development of NKT cells or intraepithelial lymphocytes, in IL-2/IL-15 receptor beta-chain-deficient mice. J Immumol 12002; 169: 4153-4160.
64. Biron CA, Brossay L. NK cells and NKT cells in innate defense against viral infections. Curr Opin Immunol 2001; 13: 458-464.
65. Navarro-Sanchez E, Despres P, Cedillo-Barron L. Innate immune responses to dengue virus. Arch Med Res 2005; 36: 425-435.
66. Li Y, Zhang T, Ho C, Orange JS, Douglas SD, Ho W-Z. Natural killer cells inhibit hepatitis C virus expression. J Leukoc Biol 2004; 76: 1171-1179.
67. Ranson T, Vosshenrich CA, Corcuff E, et al. IL-15 availability conditions homeostasis of peripheral natural killer T cells. Proc Natl Acad Sci USA 2003; 100: 2663-2668.
68. Dunne J, Lynch S, O'Farrelly C, et al. Selective expansion and partial activation of human NK cells and NK receptor-positive T cells by IL-2 and IL-15. J Immunol 2001; 167: 3129-3138.
69. Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG. NKT cells: facts, functions and fallacies. Immunol Today 2000; 21: 573-583.
70. Matsuda JL, Gapin L, Sidobre S, et al. Homeostasis of V alpha 14i NKT cells. Nat Immunol 2002; 3: 966-974.
71. Lin H, Nieda M, Nicol AJ. Differential proliferative response of NKT cell sub-populations to in vitro stimulation in presence of different cytokines. Eur J Immunol 2004; 34: 2664-2671.
72. Sharif-Askari E, Fawaz LM, Tran P, Abmad A, Menezes J. Interleukin 15-mediated induction of cytoloxic effector cells capable of eliminating Epstein-Barr virus-transformed/immortalized lymphocytes in culture. J Natl Cancer Inst 2001; 93: 1724-1732.
73. Grubor-Bauk B, Simmons A. Mayrhofer G, Speck PG. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V {aIpha} l4-J {alpha}281 TCR. J Immunol 2003; 170: 1430-1434.
74. Exley MA, Bigley NJ, Cheng O, et al. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus. J Leukoc Biol 2001; 69: 713-718.
75. Ohteki T, Suzue K, Maki C, Ota T, Koyasu S. Critical role of IL-15-IL-15R for antigen-presenting cell functions in the innate immune response. Nat Immunol 2001; 2: 1138-1143.
76. Musikacharoen T, Oguma A, Yoshikai Y, Chiba N, Masuda A, Matsuguchi T. Interleukin-15 induces IL-12 receptor betal gene expression through PU.1 and IRF 3 by targeting chromatin remodeling. Blood 2005; 105: 711-720.
77. Ferlazzo G, Pack M, Thomas D, et al. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci U S A 2004; 101: 16606-16611.
78. Andoniou CE, van Dommelen SL, Voigt V, et al. Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity. Nat Immunol 2005; 6: 1011-1019.
79. Gerosa F, Gobbi A, Zorzi P, et al. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J Immunol 2005; 174: 727-734.
80. Yoshikai Y, Nishimura H. The role of interleukin 15 in mounting an immune response against microbial infections. Microbes Infect 2000; 2: 381-389.
81. McDonald PP, Russo MP, Ferrini S, Cassatella MA. Interleukin-15 (IL-15) induces NF-kappaB activation and IL-8 production in human neutrophils. Blood 1998; 92: 4828-4835.
82. Durbin JE, Fernandez-Sesma A, Lee CK, et al. Type I IFN modulates innate and specific antiviral immunity. J Immunol 2000; 164: 4220-4228.
83. Murphy JA, Duerst RJ, Smith TJ, Morrison LA. Herpes simplex virus type 2 virion host shutoff protein regulates alpha/beta interferon but not adaptive immune responses during primary infection in vivo. J Virol 2003; 77: 9337-9345.
84. Mossman KL, Ashkar AA. Herpesviruses and the innate immune response. Viral Immunol 2005; 18: 267-281.
85. Azimi N, Shiramizu KM, Tagaya Y, Mariner J, Waldmann TA. Viral activation of interleukin-15 (IL-15): characterization of a virus-inducible element in the IL-15 promoter region. J Virol 2000; 74: 7338-7348.
86. Jinushi M, Takehara T, Tatsumi T, et al. Autocrine/paracrine IL-15 that is required for type I IFN-mediated dendritic cell expression of MHC class I-related chain A and B is impaired in hepatitis C virus infection. J Immunol 2003; 171: 5423-5429.
87. Carding SR, Egan PJ. Gammadelta T cells: functional plasticity and heterogeneity. Nat Rev Immunol 2002; 2: 336-345.
88. Kettula TO, Holm Y, Partanen J, Polvi A, Maki M. Circulating T lymphocyte subsets in coeliac disease (CoD) patients and healthy family members. Clin Exp Immunol 1998; 111: 536-540.
89. Aljurf M, Ezzat A, Musa OM. Emerging role of gammadelta T-cells in health and disease. Blood Rev 2002; 16: 203-206.
90. Chu CL, Chen SS, Wu TS, Kuo SC, Liao NS. Differential effects of IL-2 and IL-15 on the death and survival of activated TCR gamma delta+ intestinal intraepithelial lymphocytes. J Immunol 1999; 162: 1896-1903.
91. Inagaki-Ohara K, Chinen T, Matsuzaki G, et al. Mucosal T cells bearing TCRgammadelta play a protective role in intestinal inflammation. J Immunol 2004; 173: 1390-1398.
92. Halary F, Pitard V, Dlubek D, et al. Shared reactivity of V{delta}2neg {gamma} (delta) T cells against cytomegalovirus-infected cells and minor intestinal epithehal cells. J Exp Med 2005; 201: 1567-1578.
93. Kotsiopriftis M, Tanner JE, Alfieri C. Heat shock protein 90 expression in epsteinbarr virus-infected B cells promotes {gamma} {delta} T-Cell proliferation in vitro. J Virol 2005; 79: 7255-7261.
94. Alpdogan O, van den Brink MR IL-7 and IL-15: therapeutic cytokines for immunodeficiency. Trends Immunol 2005; 26: 56-64.
95. McInnes IB, Gracie JA, Harnett M, Harnett W, Liew FY. New strategies to control inflammatory synovitis: interleukin 15 and beyond. Ann Rheum Dis 2003; 62(Suppl 2): ii51-54.
96. McInnes IB, Gracie JA. Interleuldn-15: a new cytokine target for the treatment of inflammatory diseases. Curr Opin Pharmacol 2004; 4: 392-397.
97. Lazarevic V, Yankura DJ, DiVito SJ, Flynn JL. Induction of Mycobacterium tuberculosis-specific primary and secondary T-cell responses in interleukin-15-deficient mice. Infect Immun 2005; 73: 2910-2922.
98. Carr DJ, Al-khatib K, James CM, Silverman R. Interferon-beta suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathway. J Neuroimmunol 2003; 141: 40-46.
99. Toka FN, Rouse BT. Mucosal application of plasmid-encoded IL-15 sustains a highly protective anti-Herpes simplex virus immunity. J Leukoc Biol 2005; 78: 178-186.